Flurazepam is a long-acting benzodiazepine hypnotic prescribed for insomnia. Its active metabolite N-desalkylflurazepam has an exceptionally long half-life (40-250 hours), causing next-day sedation, cognitive impairment, and increased fall risk, especially in elderly users. Tolerance develops within 2-4 weeks of regular use. Withdrawal requires careful medical supervision with gradual dose tapering. Schedule IV controlled substance in the US.
Flurazepam molecular structure diagram from the DrugsPRO substance library.
Also known as: Dalmane, Dalmadorm, Felison, Flunox, Sompan, Valdorm, Ro 5-6901
Classification
Chemical: Benzodiazepine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Habit-Forming
Tag: Muscle Relaxant
Tag: Sedative
Effects
Sedation
Muscle Relaxation
Physical Euphoria
Residual Sleepiness
Anxiolytic
Sedative
Anxiety Suppression
Memory Suppression
Thought Deceleration
Emotion Suppression
Dizziness
Cognitive Impairment
Disinhibition
Dulled Perception
Routes of Administration
Oral
Dosage
Threshold: 5 mg
Light: 7.5-15 mg
Common: 15-30 mg
Strong: 30-60 mg
Heavy: 60+ mg
Duration
Onset: 0.25-0.75 h
Comeup: 0.5-1 h
Peak: 1-2 h
Offset: 8-12 h
After Effects: 24-48 h
Total Duration: 10-16 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Flurazepam - DrugsPRO substansvejledning
Flurazepam: Flurazepam is a long-acting benzodiazepine hypnotic prescribed for insomnia. Its active metabolite N-desalkylflurazepam has an exceptionally long half-life (40-250 hours), causing next-day sedation, cognitive impairment, and increased fall risk, especially in elderly users. Tolerance dev